WAY OF RISK ESTIMATION WITHIN PROGRESSING WOMAN ARTERIAL HYPERTENSIA Russian patent published in 2008 - IPC G01N33/50 G01N33/48 

FIELD: medicine.

SUBSTANCE: invention can be used for forecasting of clinical course of arterial hypertensia (AH). Erythrocyte suspension in buffer solution is made and ³¹R-nuclear magnetic resonance method is used to evaluate erythrocyte adenosine triphosphate (ATP) and 2,3-diphosphoglycerate (DPG) content in relative units. Depending on woman age, risk percentage of severe clinical course of essential AH within next 5 years is estimated on basis of forecasting tables. Method application gives possibility to register biochemical parameters of a erythrocyte energy metabolism, that provides verification of medical forecast.

EFFECT: method enables to evaluate risk percentage of severe clinical course of essential AH within next five years.

1 tbl, 1 dwg